Hydrangea quercifolia W.Bartram
Back to List

Hydrangea quercifolia

Family: HYDRANGEACEAE
Genus: Hydrangea
Species: quercifolia W.Bartram
Common names: Oak-Leaved Hydrangea
Distribution summary: S.E. U.S.A.
Habit: Shrub
Hardiness: H5 - Hardy; cold winter
Habitat: Thickets and open forest
Garden status: Currently grown
Garden location: North America (A)
Flowering months: July, August, September
Reason for growing: Medicinal, other use, prescription only medicine

Additional Notes

Hydrangea blooms are sometimes smoked to induce a hallucinogenic and euphoria inducing effect, a cheaper alternative to cannabis.

The Week, 15 Feb 2014 p. 4

Beta-dichroine a quinazolinone also called febrifugine from the leaves of hydrangeas is 64-100 times more potent than quinine as an antimalarial in animals, but extremely toxic. A synthesised tolyl derivative, methaqualone (2-methyl-3-o-tolyl-4(3H)-quinazolinone), was found to be a mild hypnotic, and marketed in the sleeping tablet, Mandrax. Widely abused and quickly banned by most countries. Illegal manufacture continues and in South Africa methaqualone is the commonest drug of abuse, mixed with cannabis and smoked.

Oakeley, Dr. Henry F. (2013). Wellcome Library notes. Link

Prescription only medicine: Hydrangine-methaqualone

Beta-dichroine a quinazolinone also called febrifugine from the leaves of hydrangeas is 64-100 times more potent than quinine as an antimalarial in animals, but extremely toxic. A synthesised tolyl derivative, methaqualone (2-methyl-3-o-tolyl-4(3H)-quinazolinone), was found to be a mild hypnotic, and marketed in the sleeping tablet, Mandrax. Widely abused and quickly banned by most countries. Illegal manufacture continues and in South Africa methaqualone is the commonest drug of abuse, mixed with cannabis and smoked.

Oakeley, Dr. Henry F. (2013). Wellcome Library notes. Link

Northern America, Southeastern U.S.A.

Image Gallery

Previous Next

We use cookies to give you the best experience and to help improve our website.

By clicking the Accept button, you agree to us doing so. Find out more

Accept